Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#625KH)
This report describes interim recommendations from the Advisory Committee on Immunization Practices for use of the Novavax vaccine in persons aged >=18 years.